CYCLOPHOSPHAZENES AS NOVEL ANTITUMOR AGENTS: X-RAY CRYSTAL STRUCTURE AND DONOR PROPERTIES OF THE HEXAZIRIDINOCYCLOTRIPHOSPHAZENE, N₃P₃(NC₂H₄)₆LABARRE JF; LEVY G; SOURNIES F et al.1980; J. MOLEC. STRUCT.; NLD; DA. 1980; VOL. 63; NO 1; PP. 127-130; BIBL. 17 REF.Article

SPECTROFLUOROMETRIC AND SPECTROPHOTOMETRIC INVESTIGATIONS OF CYCLOPHOSPHAZENE-DNA COMPLEXESBUTOUR JL; LABARRE JF; SOURNIES F et al.1980; J. MOLEC. STRUCT.; NLD; DA. 1980; VOL. 65; PP. 51-60; BIBL. 17 REF.Article

RAMAN STUDIES ON ANTICANCER INORGANIC RING-DNA INTERACTIONS. I: HEXAZIRIDINOCYCLOTRIPHOSPHAZENE N₂P₃(NC₂H₄)₆MANFAIT M; ALIX AJP; BUTOUR JL et al.1981; J. MOL. STRUCT.; ISSN 0022-2860; NLD; DA. 1981; VOL. 71; PP. 39-49; BIBL. 33 REF.Article

RAMAN AND INFRARED STUDIES ON NEW ANTICANCER INORGANIC RING SYSTEMS. I: HEXAZIRIDINOCYCLOTRIPHOSPHAZENE N₃P₃(NC₂H₄)₆MANFAIT M; ALIX AJP; LABARRE JF et al.1982; JRS, J. RAMAN SPECTROSC.; ISSN 0377-0486; GBR; DA. 1982; VOL. 12; NO 3; PP. 212-216; BIBL. 23 REF.Article

CYCLOPHOSPHAZENES AS NOVEL POTENTIAL ANTITUMOR AGENTS: X-RAY CRYSTAL STRYCTURE OF THE OCTAPYRROLIDINOCYCLOTETRAPHOSPHAZENE, N₄P₄(NC₄H₈)₈BOVIN JO; GALY J; LABARRE JF et al.1978; J. MOLEC. STRUCT.; NLD; DA. 1978; VOL. 49; NO 2; PP. 421-423; BIBL. 3 REF.Article

AN ANSWER TO THE SPIRO VERSUS ANSA DILEMMA IN CYCLOPHOSPHAZENES. II: N₃P₃CL₄(HN-(CH₂)₄-NH)GUERCH G; LABARRE JF; ROQUES R et al.1982; JOURNAL OF MOLECULAR STRUCTURE; ISSN 0022-2860; NLD; DA. 1982; VOL. 96; NO 1-2; PP. 113-120; BIBL. 11 REF.Article

NEW DESIGNS IN CYCLOPHOSPHAZENES AS ANTITUMOUR AGENTSLABARRE JF; LAHANA R; SOURNIES F et al.1980; J. CHIM. PHYS. PHYSICOCHIM. BIOL.; ISSN 0021-7689; FRA; DA. 1980; VOL. 77; NO 1; PP. 85-89; ABS. FRE; BIBL. 9 REF.Conference Paper

MASS SPECTROMETRY AS A TECHNIQUE FOR TESTING THE PURITY OF DRUGS FOR BIOLOGICAL USE: THE CASE OF NEW ANTITUMOR CYCLOPHOSPHAZENESMONSARRAT B; PROME JC; LABARRE JF et al.1980; BIOMED. MASS SPECTROM.; ISSN 0306-042X; GBR; DA. 1980; VOL. 7; NO 9; PP. 405-409; BIBL. 12 REF.Article

An answer to the SPIRO vs. ANSA dilemma in cyclophosphazenes. VI: The first polyspirodicyclotriphosphazenesSOURNIES, F; LAHANA, R; LABARRE, J.-F et al.Inorganica chimica acta. 1985, Vol 101, Num 1, pp 31-38, issn 0020-1693Article

THE ANTINEOPLASTIC ACTIVITY OF 2,2,4,4-TETRAKIS(AZIRIDINYL)-6,6, -DICHLOROCYCLOTRIPHOSPHAZA-1,3,5-TRIENE, GEM-N₃P₃AZ₄CL₂, A NOVEL ANTICANCER AGENTGUERCH G; LABARRE JF; SOURNIES F et al.1982; INORG. CHIM. ACTA; ISSN 0020-1693; ITA; DA. 1982; VOL. 66; NO 6; PP. 175-184; BIBL. 25 REF.Article

DERIVATIVES OF CIS-NPCL₂(NSOCL)₂ AND (NPCL₂)₂-NSOCL. XVI: THE PREPARATION OF SOME AZIRIDINO (ETHYLENE-IMINO) DERIVATIVES OF (NPCL₂)₂ NSOX (X=F, AZ, PH) WITH A POTENTIAL ANTICANCER ACTIVITYVAN DE GRAMPEL JC; VAN DER HUIZEN AA; JEKEL AP et al.1981; INORG. CHIM. ACTA; ISSN 0020-1693; ITA; DA. 1981; VOL. 53; NO 4; PP. 169-170; BIBL. 14 REF.Article

NEW DESIGNS IN INORGANIC RING SYSTEMS AS ANTICANCER DRUGS. ANTITUMOR ACTIVITY OF THE AZIRIDINO (ETHYLENE-IMINO) DERIVATIVES (NPAZ₂)₂NSOX WITH X=F, AZ, PHLABARRE JF; SOURNIES F; CROS S et al.1981; CANCER LETT.; ISSN 0304-3835; NLD; DA. 1981; VOL. 12; NO 3; PP. 245-250; BIBL. 5 REF.Article

AN ANSWER TO THE SPIRO VERSUS ANSA DILEMMA IN CYCLOPHOSPHAZENES. I: N₃P₃CL₄(NH(CH₂)₃NH)GUERCH G; GRAFFEUIL M; LABARRE JF et al.1982; JOURNAL OF MOLECULAR STRUCTURE; ISSN 0022-2860; NLD; DA. 1982; VOL. 95; PP. 237-244; BIBL. 20 REF.Article

ANTITUMOUR ACTIVITY OF SOME CYCLOPHOSPHAZENESLABARRE JF; FAUCHER JP; LEVY G et al.1979; EUROP. J. CANCER; GBR; DA. 1979; VOL. 15; NO 5; PP. 637-643; BIBL. 16 REF.Article

Crystal and molecular structure of the first DIBINO non-geminal macrocyclic dicyclophosphazene, {N₃P₃Cl₄[HN-(CH₂)₃-O-(CH₂)₂-O-(CH₂)₃-NH]}₂ENJALBERT, R; GALY, J; SOURNIES, F et al.Journal of molecular structure. 1990, Vol 221, pp 253-263, issn 0022-2860Article

An answer to the spiro versus ansa dilemna in cyclophosphazenes. XIV, The first macro-bino and mega-bino species from oxodiaminesSOURNIES, F; CASTERA, P; EL BAKILI, A et al.Journal of molecular structure. 1990, Vol 221, pp 239-243, issn 0022-2860Article

An answer to the spiro versus ANSA dilemma in cyclophosphazenes. XII: The first MEGA-SPIRO and MEGA-ANSA species from trioxodiaminesSOURNIES, F; ABDELAZIZ EL BAKILI; LABARRE, J.-F et al.Journal of molecular structure. 1989, Vol 196, pp 201-206, issn 0022-2860, 6 p.Article

Cyclophosphazenic cryptands serendipitous architecture from aminolysis of N₃P₃Cl₆ by 4,11-dioxatetradecane-1,14-diamineZANIN, B; SCHEIDECKER, S; SOURNIES, F et al.Journal of molecular structure. 1991, Vol 246, Num 1-2, pp 133-144, issn 0022-2860Article

Crystal and molecular structure of the monobino dicyclophosphazene N₃P₃Cl₅ [HN-(CH₂)₃-O-(CH₂)₆-O-(CH₂)₃-NH] Cl₅P₃N₃ENJALBERT, R; GALY, J; ZANIN, B et al.Journal of molecular structure. 1991, Vol 246, Num 1-2, pp 123-131, issn 0022-2860Article

Crystal and molecular structures of the first trans-macro-ansa monocyclophosphazene macrocycle, trans-N₃P₃Ci₄[HN-(CH₂)₃-O-(CH₂)₆-O-(CH₂)₃-NH]ZANIN, B; SOURNIES, F; LABARRE, J.-F et al.Journal of molecular structure. 1990, Vol 240, pp 77-88, issn 0022-2860, 12 p.Article

Synthesis and characterization of the first dispirodiansabino-cyclotriphosphazene and of the second spiroansa-cyclotriphosphazene described in the literatureSOURNIES, F; LABARRE, J.-F; HARRIS, P. J et al.Inorganica chimica acta. 1984, Vol 90, Num 3, pp L61-L63, issn 0020-1693Article

Dry media process : an efficient technique for fast regiospecific syntheses of spiranic cyclophosphazene cryptandsSCHEIDECKER, S; SEMENZIN, D; ETEMAD-MOGHADAM, G et al.Phosphorus, sulfur and silicon and the related elements (Print). 1993, Vol 80, Num 1-4, pp 85-88, issn 1042-6507Article

Modulation of polyclonal activation of lymphocytes by cyclophosphazenic compounds bearing ethylene-imino groups and vectorized by polyaminesDUEYMES, M; IN, S; LABARRE, J.-P et al.International journal of immunopharmacology. 1990, Vol 12, Num 5, pp 555-560, issn 0192-0561, 6 p.Article

An answer to the spiro versus ansa dilemma in cyclophosphazenes. XIII, Synthesis and crystal structure of the first di-MACROSPIRO and di-MEGASPIRO species from di- and tri-oxodiaminesSOURNIES, F; BAKILI, A. E; ZANIN, B et al.Journal of molecular structure. 1990, Vol 220, pp 63-77, issn 0022-2860Article

Treatment of end stage MRL-1pr/1pr mouse lupus disease by a cyclophosphazene derived drug and by cyclosporin AIN, S; DUEYMES, M; APPOLINAIRE-PILIPENKO, S et al.Journal of clinical & laboratory immunology. 1990, Vol 32, Num 2, pp 85-90, issn 0141-2760Article